FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220672220> ?p ?o ?g. }

• W4220672220 endingPage "153160" @default.
• W4220672220 startingPage "153160" @default.
• W4220672220 abstract "Flumioxazin, is a herbicide that has inhibitory activity on protoporphyrinogen oxidase (PPO), a key enzyme in the biosynthetic pathway for heme. Flumioxazin induces anemia and developmental toxicity in rats, including ventricular septal defect and embryofetal death. Studies to elucidate the mode of action (MOA) of flumioxazin as a developmental toxicant and to evaluate its relevance to humans have been undertaken. The MOA in the rat has now been elucidated. The first key event is PPO inhibition, which results in reduced heme synthesis in embryonic erythroblasts. The critical window for this effect is gestational day 12 when almost all erythroblasts are at the polychromatophilic stage, synthesizing heme very actively. Embryonic anemia/hypoxemia is induced and the heart pumps more strongly as a compensatory action during organogenesis, leading to thinning of the ventricular walls and failure of the interventricular septum to build completely and close. Investigations showed that this MOA is specific to rats and has no relevancy to humans. Flumioxazin inhibited PPO in rat hepatocyte mitochondria more strongly than in human. A 3-dimensional molecular simulation revealed that species differences in binding affinity of flumioxazin to PPO, observed previously in vitro, were due to differences in binding free energy. In vitro studies using several types of rat and human cells (erythroblasts derived from erythroleukemia cell lines, cord blood, or pluripotent stem cells), showed that flumioxazin decreased heme synthesis in rat cells but not in human cells, demonstrating a clear, qualitative species difference. Considering all available information, including data from PBPK modelling in rat and human, as well as the fact that anemia is not a symptom in patients with variegate porphyria, a congenital hereditary PPO defect, shows that the sequence of events leading to adverse effects in the rat embryo and fetus are very unlikely to occur in humans." @default.
• W4220672220 created "2022-04-03" @default.
• W4220672220 creator A5000420160 @default.
• W4220672220 creator A5002875001 @default.
• W4220672220 creator A5004853249 @default.
• W4220672220 creator A5028660046 @default.
• W4220672220 creator A5045050595 @default.
• W4220672220 creator A5046922718 @default.
• W4220672220 creator A5051441000 @default.
• W4220672220 creator A5055865861 @default.
• W4220672220 creator A5067138360 @default.
• W4220672220 creator A5070970552 @default.
• W4220672220 date "2022-04-01" @default.
• W4220672220 modified "2023-09-27" @default.
• W4220672220 title "Flumioxazin, a PPO inhibitor: A weight-of-evidence consideration of its mode of action as a developmental toxicant in the rat and its relevance to humans" @default.
• W4220672220 cites W1821629295 @default.
• W4220672220 cites W1907243625 @default.
• W4220672220 cites W1963592892 @default.
• W4220672220 cites W1967068783 @default.
• W4220672220 cites W1968548800 @default.
• W4220672220 cites W1983286872 @default.
• W4220672220 cites W1991391843 @default.
• W4220672220 cites W1992976934 @default.
• W4220672220 cites W1995878016 @default.
• W4220672220 cites W1997768654 @default.
• W4220672220 cites W2002918938 @default.
• W4220672220 cites W2023941860 @default.
• W4220672220 cites W2031430283 @default.
• W4220672220 cites W2036219339 @default.
• W4220672220 cites W2066658921 @default.
• W4220672220 cites W2068761666 @default.
• W4220672220 cites W2070906838 @default.
• W4220672220 cites W2071906583 @default.
• W4220672220 cites W2075908866 @default.
• W4220672220 cites W2082478253 @default.
• W4220672220 cites W2085157180 @default.
• W4220672220 cites W2100681150 @default.
• W4220672220 cites W2107857612 @default.
• W4220672220 cites W2146976723 @default.
• W4220672220 cites W2148468520 @default.
• W4220672220 cites W2253160311 @default.
• W4220672220 cites W2499457821 @default.
• W4220672220 cites W2532339091 @default.
• W4220672220 cites W2586129518 @default.
• W4220672220 cites W2622396981 @default.
• W4220672220 cites W2727192332 @default.
• W4220672220 cites W2771050118 @default.
• W4220672220 cites W2774671567 @default.
• W4220672220 cites W2806579813 @default.
• W4220672220 cites W3082816727 @default.
• W4220672220 cites W3087072509 @default.
• W4220672220 cites W3092858707 @default.
• W4220672220 cites W3107673678 @default.
• W4220672220 cites W4226321926 @default.
• W4220672220 cites W2129217154 @default.
• W4220672220 doi "https://doi.org/10.1016/j.tox.2022.153160" @default.
• W4220672220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35367320" @default.
• W4220672220 hasPublicationYear "2022" @default.
• W4220672220 type Work @default.
• W4220672220 citedByCount "3" @default.
• W4220672220 countsByYear W42206722202022 @default.
• W4220672220 countsByYear W42206722202023 @default.
• W4220672220 crossrefType "journal-article" @default.
• W4220672220 hasAuthorship W4220672220A5000420160 @default.
• W4220672220 hasAuthorship W4220672220A5002875001 @default.
• W4220672220 hasAuthorship W4220672220A5004853249 @default.
• W4220672220 hasAuthorship W4220672220A5028660046 @default.
• W4220672220 hasAuthorship W4220672220A5045050595 @default.
• W4220672220 hasAuthorship W4220672220A5046922718 @default.
• W4220672220 hasAuthorship W4220672220A5051441000 @default.
• W4220672220 hasAuthorship W4220672220A5055865861 @default.
• W4220672220 hasAuthorship W4220672220A5067138360 @default.
• W4220672220 hasAuthorship W4220672220A5070970552 @default.
• W4220672220 hasConcept C104317684 @default.
• W4220672220 hasConcept C107459253 @default.
• W4220672220 hasConcept C121587506 @default.
• W4220672220 hasConcept C126322002 @default.
• W4220672220 hasConcept C145103041 @default.
• W4220672220 hasConcept C181199279 @default.
• W4220672220 hasConcept C202751555 @default.
• W4220672220 hasConcept C2776217839 @default.
• W4220672220 hasConcept C2780473477 @default.
• W4220672220 hasConcept C29730261 @default.
• W4220672220 hasConcept C30503417 @default.
• W4220672220 hasConcept C55493867 @default.
• W4220672220 hasConcept C71924100 @default.
• W4220672220 hasConcept C86803240 @default.
• W4220672220 hasConcept C95444343 @default.
• W4220672220 hasConcept C98274493 @default.
• W4220672220 hasConceptScore W4220672220C104317684 @default.
• W4220672220 hasConceptScore W4220672220C107459253 @default.
• W4220672220 hasConceptScore W4220672220C121587506 @default.
• W4220672220 hasConceptScore W4220672220C126322002 @default.
• W4220672220 hasConceptScore W4220672220C145103041 @default.
• W4220672220 hasConceptScore W4220672220C181199279 @default.
• W4220672220 hasConceptScore W4220672220C202751555 @default.
• W4220672220 hasConceptScore W4220672220C2776217839 @default.
• W4220672220 hasConceptScore W4220672220C2780473477 @default.

• next